We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Dr. Reddy's Laboratories
RDY
$10.1B
| $584K | 0.01% |
+51,125
| New | +$542K |
|
352
Credicorp
BAP
$29.6B
| $582K | 0.01% |
4,135
-712
| -15% | -$105K |
|
353
ResMed
RMD
$34B
| $578K | 0.01% |
8,050
| – | – |
|
|
FITB
354
Fifth Third Bancorp
FITB
$49.7B
| $573K | 0.01% |
30,372
+9
| +0% | +$170 |
|
|
GGP
355
DELISTED
GGP Inc.
GGP
| $561K | 0.01% |
19,000
| – | – |
|
356
Illumina
ILMN
$34.4B
| $557K | 0.01% |
3,084
-2,209
| -42% | -$416K |
|
|
FMBI
357
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $555K | 0.01% |
31,946
| – | – |
|
|
FISV
358
Fiserv Inc
FISV
$28B
| $553K | 0.01% |
13,920
-770
| -5% | -$29.4K |
|
|
EXAM
359
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $552K | 0.01% |
13,265
-683
| -5% | -$27.5K |
|
|
NFX
360
DELISTED
Newfield Exploration
NFX
| $550K | 0.01% |
15,675
-305
| -2% | -$9.24K |
|
|
NPSN
361
DELISTED
NASPERS LTD
NPSN
| $547K | 0.01% |
3,545
+1,265
| +55% | +$195K |
|
|
EFOR
362
Everforth Inc
EFOR
$1.3B
| $543K | 0.01% |
14,158
+1,945
| +16% | +$70.9K |
|
363
Vanguard Dividend Appreciation ETF
VIG
$113B
| $541K | 0.01% |
6,724
-1,143
| -15% | -$92.7K |
|
364
Mondelez International
MDLZ
$79.7B
| $533K | 0.01% |
14,763
-453
| -3% | -$16.4K |
|
365
Kaiser Aluminum
KALU
$2.56B
| $531K | 0.01% |
6,910
-390
| -5% | -$28.6K |
|
366
iShares S&P India Nifty 50 Index Fund
INDY
$551M
| $530K | 0.01% |
16,925
+5,540
| +49% | +$177K |
|
367
Air Products & Chemicals
APD
$68B
| $524K | 0.01% |
3,746
-54
| -1% | -$7.47K |
|
368
Canadian Solar
CSIQ
$949M
| $524K | 0.01% |
15,680
-775
| -5% | -$21.4K |
|
369
Intercontinental Exchange
ICE
$90.5B
| $522K | 0.01% |
11,190
-40
| -0.4% | -$1.8K |
|
|
SGNT
370
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $518K | 0.01% |
22,261
| – | – |
|
|
MHG
371
DELISTED
Marine Harvest ASA
MHG
| $515K | 0.01% |
45,165
-2,710
| -6% | -$34.7K |
|
372
Ambev
ABEV
$44.4B
| $514K | 0.01% |
89,299
+20,712
| +30% | +$129K |
|
373
FirstCash
FCFS
$9.72B
| $510K | 0.01% |
10,960
+4,881
| +80% | +$243K |
|
374
Raymond James Financial
RJF
$33.9B
| $508K | 0.01% |
13,410
+3,675
| +38% | +$137K |
|
|
PX
375
DELISTED
Praxair Inc
PX
| $503K | 0.01% |
4,166
-306
| -7% | -$38.3K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.